Back to top
more

AngioDynamics (ANGO)

(Delayed Data from NSDQ)

$6.04 USD

6.04
310,292

-0.38 (-5.92%)

Updated May 17, 2024 04:00 PM ET

After-Market: $6.05 +0.01 (0.17%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 249)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for ANGO

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

3 items in cart

View Cart/Checkout

AngioDynamics, Inc. [ANGO]

Reports for Purchase

Showing records 381 - 400 ( 408 total )

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 381

06/13/2011

Company Report

Pages: 7

Downgrading to UNDERPERFORM, Lowering PT to $12 CEO Out, Q4 Results Fall Short, Slashing our FY 2012 Outlook

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 382

05/25/2011

Daily Note

Pages: 4

Loses Distribution Rights at Year-End to Product Representing 13% of Sales

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 10.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 383

04/18/2011

Daily Note

Pages: 19

March Quarter Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 50.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 384

04/08/2011

Company Report

Pages: 8

Price: 24.95

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 385

04/06/2011

Company Report

Pages: 2

Quarterly results growing more volatile

Provider: G.RESEARCH, LLC

Analyst: JONAS J

Price: 10.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 386

04/05/2011

Company Report

Pages: 8

Stuck in a Choppy Cycle -Q3 Beats

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 387

01/07/2011

Company Report

Pages: 8

Price: 24.95

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 388

01/05/2011

Company Report

Pages: 2

Q2 results show sequential improvement.

Provider: G.RESEARCH, LLC

Analyst: JONAS J

Price: 10.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 389

01/04/2011

Company Report

Pages: 8

Flat Q2 Sales and Earnings -- Sales A Bit Light, EPS On Track

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 390

10/18/2010

Daily Note

Pages: 29

Med Tech September Quarter Preview: Stagnation for Most Large Device Markets

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 75.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 391

10/12/2010

Company Report

Pages: 8

Price: 24.95

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 392

10/08/2010

Company Report

Pages: 2

Q1 Results; Slow improvement from here

Provider: G.RESEARCH, LLC

Analyst: JONAS J

Price: 10.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 393

10/08/2010

Company Report

Pages: 6

Q1 results in line with disappointing

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 394

09/08/2010

Company Report

Pages: 7

Cutting FY 2011 Projections in Wake of Q1 Shortfall

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 395

08/17/2010

Industry Report

Pages: 13

MEDTECH TECHNICAL PAIR TRADE IDEAS

Provider: CAPSTONE INVESTMENTS

Analyst: SINE B

Price: 50.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 396

07/19/2010

Company Report

Pages: 2

Solid Q4 results but more IRE delays

Provider: G.RESEARCH, LLC

Analyst: JONAS J

Price: 10.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 397

07/19/2010

Daily Note

Pages: 21

Medical Technology -Med Tech June Quarter Preview: Nothing on the Horizon to Lift the Sector Out of the Doldrums, Although Select Small-Cap Names Should Shine Through

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 75.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 398

07/19/2010

Company Report

Pages: 8

Price: 24.95

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 399

07/16/2010

Company Report

Pages: 6

Very Strong Quarter as ANGO Rises Above Gross Margin Pressures- FY 2011 EPS Guidance a Bit Light -Timing Setback for NanoKnife U.S. Clinical Studies

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: AngioDynamics, Inc.

Industry: Medical - Instruments

Record: 400

07/14/2010

Company Report

Pages: 8

Q4 Likely In Line, Showing Continued Pressure on Core Business FY11 Consensus Numbers Appear Too High As Always, NanoKnife Progress Remains the Wild Card

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party